Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nucleophosmin 1 pseudogene 48 (NPM1P48) is a human pseudogene related by sequence similarity to NPM1, which encodes nucleophosmin, a nucleolar phosphoprotein involved in ribosome biogenesis, cell cycle regulation, and genomic stability[1][3][5]. As a pseudogene, NPM1P48 does not encode a functional protein and is generally considered non-coding. Pseudogenes like NPM1P48 can sometimes play regulatory roles at the RNA level, particularly by acting as molecular decoys for microRNAs (ceRNAs), thereby influencing the expression of their protein-coding paralogs or related pathways[2][4][6]. However, there is no direct evidence that NPM1P48 itself is involved in disease, therapy, or acts as a druggable target. Current scientific understanding emphasizes its place as a member of the broader pseudogene family rather than as a functional protein or clinical target. Key Clarifications: - NPM1P48 is distinct from the NPM1 gene, which codes for an important multifunctional nucleolar protein, a known cancer gene and a key target in acute myeloid leukemia[1][3][5]. NPM1P48, as a pseudogene, does not encode any functional protein and has no established clinical relevance or druggability. - Pseudogenes can sometimes affect biological networks by acting as decoys for microRNAs or producing regulatory RNAs[2][4][6], but evidence is lacking for such a function in this specific pseudogene. Limitations: Currently, there is no direct research literature about specific functions, disease roles, or pharmacological targeting of NPM1P48. All functional and disease associations for pseudogenes are inferred from the general behavior of other pseudogenes, not from any direct evidence involving NPM1P48 itself.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nucleophosmin 1 pseudogene 48 (NPM1P48).